{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:34Z","timestamp":1786985074996,"version":"build-2736575974"},"reference-count":108,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.bcp.2014.01.032","type":"journal-article","created":{"date-parts":[[2014,2,7]],"date-time":"2014-02-07T13:02:07Z","timestamp":1391778127000},"page":"486-494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Alzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: Maintenance of brain iron homeostasis"],"prefix":"10.1016","volume":"88","author":[{"given":"Sanghamitra","family":"Bandyopadhyay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack T.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2014.01.032_bib0005","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","article-title":"Global prevalence of dementia: a Delphi consensus study","volume":"366","author":"Ferri","year":"2005","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.bcp.2014.01.032_bib0010","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.cellsig.2012.05.008","article-title":"Alzheimer culprits: cellular crossroads and interplay","volume":"24","author":"Claeysen","year":"2012","journal-title":"Cell Signalling"},{"key":"10.1016\/j.bcp.2014.01.032_bib0015","doi-asserted-by":"crossref","first-page":"a006270","DOI":"10.1101\/cshperspect.a006270","article-title":"Trafficking and proteolytic processing of APP","volume":"2","author":"Haass","year":"2012","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2014.01.032_bib0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1471-4159.2011.07519.x","article-title":"Proteolytic processing of Alzheimer's beta-amyloid precursor protein","volume":"120","author":"Zhang","year":"2012","journal-title":"J Neurochem"},{"key":"10.1016\/j.bcp.2014.01.032_bib0025","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1517\/14728222.2010.525352","article-title":"Novel drug targets based on metallobiology of Alzheimer's disease","volume":"14","author":"Bandyopadhyay","year":"2010","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.bcp.2014.01.032_bib0030","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.2174\/092986707782360060","article-title":"Role of the APP non-amyloidogenic signaling pathway and targeting alpha-secretase as an alternative drug target for treatment of Alzheimer's disease","volume":"14","author":"Bandyopadhyay","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bcp.2014.01.032_bib0035","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","article-title":"Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial","volume":"372","author":"Holmes","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2014.01.032_bib0040","doi-asserted-by":"crossref","first-page":"145ra05","DOI":"10.1126\/scitranslmed.3004145","article-title":"Reversal of paralysis and reduced inflammation from peripheral administration of beta-amyloid in TH1 and TH17 versions of experimental autoimmune encephalomyelitis","volume":"4","author":"Grant","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bcp.2014.01.032_bib0045","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A phase 3 trial of semagacestat for treatment of Alzheimer's disease","volume":"369","author":"Doody","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bcp.2014.01.032_bib0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jneuroim.2012.09.008","article-title":"A peptide prime-DNA boost immunization protocol provides significant benefits as a new generation Abeta42 DNA vaccine for Alzheimer disease","volume":"254","author":"Lambracht-Washington","year":"2013","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.bcp.2014.01.032_bib0055","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cell.2010.08.014","article-title":"Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease","volume":"142","author":"Duce","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2014.01.032_bib0060","doi-asserted-by":"crossref","first-page":"31217","DOI":"10.1074\/jbc.M110.149161","article-title":"Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1","volume":"285","author":"Cho","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.01.032_bib0065","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nrn1537","article-title":"Iron, brain ageing and neurodegenerative disorders","volume":"5","author":"Zecca","year":"2004","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bcp.2014.01.032_bib0070","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1212\/01.wnl.0000262033.01945.9a","article-title":"Individual dopaminergic neurons show raised iron levels in Parkinson disease","volume":"68","author":"Oakley","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.bcp.2014.01.032_bib0075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neulet.2005.07.032","article-title":"Increased susceptibility to oxidative stress in scrapie-infected neuroblastoma cells is associated with intracellular iron status","volume":"389","author":"Fernaeus","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bcp.2014.01.032_bib0080","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/ana.1252","article-title":"Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord","volume":"50","author":"Olsen","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bcp.2014.01.032_bib0085","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000065696","article-title":"Iron: a pathological mediator of Alzheimer disease","volume":"24","author":"Bishop","year":"2002","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.bcp.2014.01.032_bib0090","doi-asserted-by":"crossref","first-page":"e65978","DOI":"10.1371\/journal.pone.0065978","article-title":"Novel 5\u2032 untranslated region directed blockers of iron-regulatory protein-1 dependent amyloid precursor protein translation: implications for Down syndrome and Alzheimer's disease","volume":"8","author":"Bandyopadhyay","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.bcp.2014.01.032_bib0095","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1042\/BJ20101825","article-title":"Regulation of cellular iron metabolism","volume":"434","author":"Wang","year":"2012","journal-title":"Biochem J"},{"key":"10.1016\/j.bcp.2014.01.032_bib0100","doi-asserted-by":"crossref","first-page":"18148","DOI":"10.1016\/S0021-9258(19)37165-0","article-title":"Ferritin: a cytoprotective antioxidant strategem of endothelium","volume":"267","author":"Balla","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.01.032_bib0105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0169-328X(97)00133-2","article-title":"Reversible ischemia increases levels of Alzheimer amyloid protein precursor without increasing levels of mRNA in the rabbit spinal cord","volume":"49","author":"Komori","year":"1997","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.bcp.2014.01.032_bib0110","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/ana.10751","article-title":"Magnetic resonance imaging shows delayed ischemic striatal neurodegeneration","volume":"54","author":"Fujioka","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bcp.2014.01.032_bib0115","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1073\/pnas.91.16.7450","article-title":"Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta\/A4 protein precursor","volume":"91","author":"Roch","year":"1994","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2014.01.032_bib0120","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/jnr.20864","article-title":"Interleukin-1alpha stimulates non-amyloidogenic pathway by alpha-secretase (ADAM-10 and ADAM-17) cleavage of APP in human astrocytic cells involving p38 MAP kinase","volume":"84","author":"Bandyopadhyay","year":"2006","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.bcp.2014.01.032_bib0125","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.0959-9673.2005.00429.x","article-title":"Amyloid-beta in Alzheimer's disease: the horse or the cart? Pathogenic or protective","volume":"86","author":"Lee","year":"2005","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.bcp.2014.01.032_bib0130","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3233\/JAD-2009-1151","article-title":"Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta","volume":"18","author":"Castellani","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bcp.2014.01.032_bib0135","doi-asserted-by":"crossref","first-page":"e72177","DOI":"10.1371\/journal.pone.0072177","article-title":"The amyloid precursor protein (APP) does not have a ferroxidase site in its E2 domain","volume":"8","author":"Honarmand Ebrahimi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2014.01.032_bib0140","first-page":"378278","article-title":"Dysregulation of iron metabolism in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis","volume":"2011","author":"Oshiro","year":"2011","journal-title":"Adv Pharmacol Sci"},{"key":"10.1016\/j.bcp.2014.01.032_bib0145","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0006-291X(02)02999-6","article-title":"Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase","volume":"301","author":"Asai","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2014.01.032_bib0150","article-title":"ADAM10 in synaptic physiology and pathology","author":"Musardo","year":"2013","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.bcp.2014.01.032_bib0155","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1172\/JCI65401","article-title":"Endocytosis of synaptic ADAM10 in neuronal plasticity and Alzheimer's disease","volume":"123","author":"Marcello","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2014.01.032_bib0160","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1093\/brain\/awq217","article-title":"Blocking ADAM10 synaptic trafficking generates a model of sporadic Alzheimer's disease","volume":"133","author":"Epis","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.bcp.2014.01.032_bib0165","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/156720512799361664","article-title":"The Role of the anti-amyloidogenic secretase ADAM10 in shedding the APP-like proteins","volume":"9","author":"Endres","year":"2012","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.bcp.2014.01.032_bib0170","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3233\/JAD-2009-0952","article-title":"Effect of a dominant-negative form of ADAM10 in a mouse model of Alzheimer's disease","volume":"16","author":"Schroeder","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bcp.2014.01.032_bib0175","doi-asserted-by":"crossref","first-page":"24007","DOI":"10.1016\/S0021-9258(19)51039-0","article-title":"Amyloid precursor protein mRNA stability is controlled by a 29-base element in the 3\u2032-untranslated region","volume":"269","author":"Zaidi","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.01.032_bib0180","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1371\/journal.pbio.0050052","article-title":"FMRP mediates mGluR5-dependent translation of amyloid precursor protein","volume":"5","author":"Westmark","year":"2007","journal-title":"PLoS Biol"},{"key":"10.1016\/j.bcp.2014.01.032_bib0185","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1073\/pnas.1013343108","article-title":"Non-ATG-initiated translation directed by microsatellite expansions","volume":"108","author":"Zu","year":"2011","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2014.01.032_bib0190","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1126\/science.1232927","article-title":"The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD\/ALS","volume":"339","author":"Mori","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.bcp.2014.01.032_bib0195","first-page":"215","article-title":"Medicinal inorganic chemistry symposium series","volume":"903","author":"Rogers","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bcp.2014.01.032_bib0200","doi-asserted-by":"crossref","first-page":"45518","DOI":"10.1074\/jbc.M207435200","article-title":"An iron-responsive element type II in the 5\u2032-untranslated region of the Alzheimer's amyloid precursor protein transcript","volume":"277","author":"Rogers","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.01.032_bib0205","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-3-211-33328-0_25","article-title":"Metal specificity of an iron-responsive element in Alzheimer's APP mRNA 5\u2032 untranslated region, tolerance of SH-SY5Y and H4 neural cells to desferrioxamine, clioquinol, VK-28, and a piperazine chelator","author":"Bandyopadhyay","year":"2006","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.bcp.2014.01.032_bib0210","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1001\/archneur.59.11.1793","article-title":"Polymorphisms in the promoter of the human APP gene: functional evaluation and allele frequencies in Alzheimer disease","volume":"59","author":"Athan","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.bcp.2014.01.032_bib0215","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1196\/annals.1332.003","article-title":"The integrated role of desferrioxamine and phenserine targeted to an iron-responsive element in the APP-mRNA 5\u2032-untranslated region","volume":"1035","author":"Venti","year":"2004","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.bcp.2014.01.032_bib0220","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/sj.mp.4001937","article-title":"The 5\u2032-untranslated region of Parkinson's disease alpha-synuclein messengerRNA contains a predicted iron responsive element","volume":"12","author":"Friedlich","year":"2007","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bcp.2014.01.032_bib0225","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3390\/ijms10031226","article-title":"Physiological and pathological role of alpha-synuclein in Parkinson's disease through iron mediated oxidative stress; the role of a putative iron-responsive element","volume":"10","author":"Olivares","year":"2009","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bcp.2014.01.032_bib0230","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.bbagen.2008.12.001","article-title":"Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases","volume":"1790","author":"Cahill","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2014.01.032_bib0235","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/1874205X00802010051","article-title":"Serum ferritin and metal levels as risk factors for ALS","volume":"2","author":"Qureshi","year":"2008","journal-title":"Open Neurol J"},{"key":"10.1016\/j.bcp.2014.01.032_bib0240","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2174\/1389450043345272","article-title":"Metal and inflammatory targets for Alzheimer's disease","volume":"5","author":"Rogers","year":"2004","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.bcp.2014.01.032_bib0245","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S1357-2725(99)00080-1","article-title":"Iron-regulatory proteins, iron-responsive elements and ferritin mRNA translation","volume":"31","author":"Thomson","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.bcp.2014.01.032_bib0250","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1261\/rna.464807","article-title":"Evolution of the iron-responsive element","volume":"13","author":"Piccinelli","year":"2007","journal-title":"RNA"},{"key":"10.1016\/j.bcp.2014.01.032_bib0255","doi-asserted-by":"crossref","first-page":"24650","DOI":"10.1074\/jbc.M703167200","article-title":"Excess capacity of the iron regulatory protein system","volume":"282","author":"Wang","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.01.032_bib0260","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/84859","article-title":"Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice","volume":"27","author":"LaVaute","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.bcp.2014.01.032_bib0265","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.cmet.2013.01.007","article-title":"The IRP1-HIF-2alpha axis coordinates iron and oxygen sensing with erythropoiesis and iron absorption","volume":"17","author":"Anderson","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.bcp.2014.01.032_bib0270","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0306-4522(03)00590-6","article-title":"Mechanisms and regulation of transferrin and iron transport in a model blood\u2013brain barrier system","volume":"121","author":"Burdo","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.bcp.2014.01.032_bib0275","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.brainres.2003.10.066","article-title":"Expression of the iron transporter ferroportin in synaptic vesicles and the blood\u2013brain barrier","volume":"1001","author":"Wu","year":"2004","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.bcp.2014.01.032_bib0545","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/2051-5960-1-55","article-title":"The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer's disease","volume":"1","author":"Raha","year":"2013","journal-title":"Acta Neuropathol Commun."},{"key":"10.1016\/j.bcp.2014.01.032_bib0285","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0014-5793(01)03189-1","article-title":"Iron-dependent regulation of the divalent metal ion transporter","volume":"509","author":"Gunshin","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2014.01.032_bib0290","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1097-2765(00)80425-6","article-title":"A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation","volume":"5","author":"McKie","year":"2000","journal-title":"Mol Cell"},{"key":"10.1016\/j.bcp.2014.01.032_bib0295","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/jcb.22617","article-title":"Ferroportin1 and hephaestin overexpression attenuate iron-induced oxidative stress in MES23.5 dopaminergic cells","volume":"110","author":"Song","year":"2014","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bcp.2014.01.032_bib0300","doi-asserted-by":"crossref","first-page":"30032","DOI":"10.1074\/jbc.M502951200","article-title":"The acute box cis-element in human heavy ferritin mRNA 5\u2032-untranslated region is a unique translation enhancer that binds poly(C)-binding proteins","volume":"280","author":"Thomson","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.01.032_bib0305","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.1074\/jbc.274.10.6421","article-title":"Translation of the Alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5\u2032-untranslated region sequences","volume":"274","author":"Rogers","year":"1999","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.bcp.2014.01.032_bib0310","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1136\/jnnp.2006.113514","article-title":"APP locus duplication in a Finnish family with dementia and intracerebral haemorrhage","volume":"78","author":"Rovelet-Lecrux","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bcp.2014.01.032_bib0315","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1212\/01.wnl.0000255938.33739.46","article-title":"Variations in the APP gene promoter region and risk of Alzheimer disease","volume":"68","author":"Guyant-Marechal","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.bcp.2014.01.032_bib0320","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ng1718","article-title":"APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy","volume":"38","author":"Rovelet-Lecrux","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.bcp.2014.01.032_bib0325","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.4161\/cc.10.9.15478","article-title":"Alzheimer Abeta disrupts the mitotic spindle and directly inhibits mitotic microtubule motors","volume":"10","author":"Borysov","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bcp.2014.01.032_bib0330","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1091\/mbc.e09-10-0850","article-title":"Alzheimer Abeta peptide induces chromosome mis-segregation and aneuploidy, including trisomy 21: requirement for tau and APP","volume":"21","author":"Granic","year":"2012","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.bcp.2014.01.032_bib0335","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.neurobiolaging.2006.10.027","article-title":"Alzheimer's presenilin 1 causes chromosome missegregation and aneuploidy","volume":"29","author":"Boeras","year":"2008","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.bcp.2014.01.032_bib0340","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1086\/504044","article-title":"Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease","volume":"78","author":"Theuns","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bcp.2014.01.032_bib0345","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-2164-14-68","article-title":"PuF, an antimetastatic and developmental signaling protein, interacts with the Alzheimer's amyloid-beta precursor protein via a tissue-specific proximal regulatory element (PRE)","volume":"14","author":"Lahiri","year":"2013","journal-title":"BMC Genomics"},{"key":"10.1016\/j.bcp.2014.01.032_bib0350","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","article-title":"Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE","volume":"286","author":"Vassar","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bcp.2014.01.032_bib0355","doi-asserted-by":"crossref","first-page":"12787","DOI":"10.1523\/JNEUROSCI.3657-09.2009","article-title":"The beta-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential","volume":"29","author":"Vassar","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2014.01.032_bib0360","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuron.2006.05.022","article-title":"Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration","volume":"51","author":"Salehi","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.bcp.2014.01.032_bib0365","doi-asserted-by":"crossref","first-page":"7ra17","DOI":"10.1126\/scitranslmed.3000258","article-title":"Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome","volume":"1","author":"Salehi","year":"2009","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bcp.2014.01.032_bib0370","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1042\/BST0361282","article-title":"Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease","volume":"36","author":"Rogers","year":"2009","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.bcp.2014.01.032_bib0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.3000258","article-title":"Restoration of norepinephrine-modulated contextrual memory in a mouse model of down syndrome","volume":"1","author":"Salehi","year":"2009","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bcp.2014.01.032_bib0380","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1523\/JNEUROSCI.1547-09.2009","article-title":"The Down syndrome critical region is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome","volume":"29","author":"Belichenko","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2014.01.032_bib0385","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12031-002-0014-6","article-title":"Alzheimer's disease drug discovery targeted to the APP mRNA 5\u2032 untranslated region","volume":"19","author":"Rogers","year":"2002","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.bcp.2014.01.032_bib0390","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/archneur.60.12.1685","article-title":"Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial","volume":"60","author":"Ritchie","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.bcp.2014.01.032_bib0395","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2174\/1567205011310050005","article-title":"Efficacy and toxicity of clioquinol treatment and A-beta42 inoculation in the APP\/PSI mouse model of Alzheimer's disease","volume":"10","author":"Zhang","year":"2013","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.bcp.2014.01.032_bib0400","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3233\/JAD-2010-1390","article-title":"PBT2 rapidly improves cognition in Alzheimer's disease: additional phase II analyses","volume":"20","author":"Faux","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bcp.2014.01.032_bib0405","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1474-4422(08)70167-4","article-title":"Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial","volume":"7","author":"Lannfelt","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.bcp.2014.01.032_bib0410","article-title":"A novel approach to rapidly prevent age-related cognitive decline","volume":"28","author":"Adlard","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.bcp.2014.01.032_bib0415","doi-asserted-by":"crossref","first-page":"e17669","DOI":"10.1371\/journal.pone.0017669","article-title":"Metal ionophore treatment restores dendritic spine density and synaptic protein levels in a mouse model of Alzheimer's disease","volume":"6","author":"Adlard","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.bcp.2014.01.032_bib0420","first-page":"592","article-title":"Tetrathiomolybdate, a copper chelator for the treatment of Wilson disease, pulmonary fibrosis and other indications","volume":"11","author":"Medici","year":"2008","journal-title":"IDrugs"},{"key":"10.1016\/j.bcp.2014.01.032_bib0425","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2174\/156720506777632835","article-title":"RNA therapeutics directed to the non coding regions of APP mRNA, in vivo anti-amyloid efficacy of paroxetine, erythromycin, and N-acetyl cysteine","volume":"3","author":"Tucker","year":"2006","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.bcp.2014.01.032_bib0430","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1124\/jpet.106.112102","article-title":"The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and mice","volume":"320","author":"Lahiri","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2014.01.032_bib0435","doi-asserted-by":"crossref","first-page":"7605","DOI":"10.1073\/pnas.131152998","article-title":"Phenserine regulates translation of beta-amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development","volume":"98","author":"Shaw","year":"2001","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2014.01.032_bib0440","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1385\/JMN:24:1:129","article-title":"FDA-preapproved drugs targeted to the translational regulation and processing of the amyloid precursor protein","volume":"24","author":"Morse","year":"2004","journal-title":"J Mol Neurosci"},{"issue":"41","key":"10.1016\/j.bcp.2014.01.032_bib0445","doi-asserted-by":"crossref","first-page":"31217","DOI":"10.1074\/jbc.M110.149161","article-title":"Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1","volume":"285","author":"Cho","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.01.032_bib0450","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1177\/1087057106287271","article-title":"A high-throughput drug screen targeted to the 5\u2032 untranslated region of Alzheimer amyloid precursor protein mRNA","volume":"11","author":"Bandyopadhyay","year":"2006","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.bcp.2014.01.032_bib0455","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/0140-6736(91)92978-B","article-title":"Intramuscular desferrioxamine in patients with Alzheimer's disease","volume":"337","author":"Crapper McLachlan","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2014.01.032_bib0460","doi-asserted-by":"crossref","first-page":"45518","DOI":"10.1074\/jbc.M207435200","article-title":"An iron-responsive element type II in the 5\u2032 untranslated region of the Alzheimer's amyloid precursor protein transcript","volume":"277","author":"Rogers","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.01.032_bib0465","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1385\/JMN:20:3:267","article-title":"Drug discovery targeted to the Alzheimer's APP mRNA 5\u2032-untranslated region: the action of paroxetine and dimercaptopropanol","volume":"20","author":"Payton","year":"2003","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.bcp.2014.01.032_bib0470","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/jnnp-2012-302589","article-title":"Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-beta peptide and tau levels: target engagement, tolerability and pharmacokinetics in humans","volume":"83","author":"Maccecchini","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bcp.2014.01.032_bib0550","series-title":"Probe Reports from the NIH Molecular Libraries Program [Internet]","author":"Ross","year":"2010"},{"key":"10.1016\/j.bcp.2014.01.032_bib0480","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3233\/JAD-130218","article-title":"Prion protein regulates iron transport by functioning as a ferrireductase","volume":"35","author":"Singh","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bcp.2014.01.032_bib0485","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/j.jalz.2007.11.011","article-title":"A perspective on risks that impede development of drugs to modify the course of Alzheimer's disease: can they be reduced","volume":"4","author":"Mohs","year":"2008","journal-title":"Alzheimers Dementia"},{"issue":"4","key":"10.1016\/j.bcp.2014.01.032_bib0490","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm840","article-title":"Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report","volume":"9","author":"Nicoll","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.bcp.2014.01.032_bib0495","doi-asserted-by":"crossref","unstructured":"Farlow M, Arnold SE, van Dyck CH, Aisen PS, Snider BJ, Porsteinsson AP, et al. Safety and biomarker effects of solanezumab in patients with Alzheimer's disease. Alzheimers Dement;8:261\u201371.","DOI":"10.1016\/j.jalz.2011.09.224"},{"key":"10.1016\/j.bcp.2014.01.032_bib0500","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrd3842","article-title":"Sting of Alzheimer's failures offset by upcoming prevention trials","volume":"11","author":"Mullard","year":"2012","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.bcp.2014.01.032_bib0505","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1471-4159.2009.06181.x","article-title":"The amyloid hypothesis for Alzheimer's disease: a critical reappraisal","volume":"110","author":"Hardy","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.bcp.2014.01.032_bib0510","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/01.qai.0000243092.40490.26","article-title":"Long-term results of initial therapy with abacavir and Lamivudine combined with Efavirenz, Amprenavir\/Ritonavir, or Stavudine","volume":"43","author":"Bartlett","year":"2006","journal-title":"JAIDS, J Acquired Immune Defic Syndr"},{"key":"10.1016\/j.bcp.2014.01.032_bib0515","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1172\/JCI71784","article-title":"Lack of protease inhibitor resistance following treatment failure\u2014too good to be true","volume":"123","author":"Bartlett","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2014.01.032_bib0520","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0092-8674(95)90073-X","article-title":"beta-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity","volume":"81","author":"Zheng","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2014.01.032_bib0525","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0006-8993(99)01861-2","article-title":"Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice","volume":"842","author":"White","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.bcp.2014.01.032_bib0530","first-page":"142372","article-title":"The anticholinesterase phenserine and its enantiomer posiphen as 5\u2032 untranslated-region-directed translation blockers of the Parkinson's alpha synuclein expression","volume":"2012","author":"Mikkilineni","year":"2012","journal-title":"Parkinson's Dis"},{"key":"10.1016\/j.bcp.2014.01.032_bib0535","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00702-010-0513-5","article-title":"The alpha-synuclein 5\u2032 untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen","volume":"118","author":"Rogers","year":"2011","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bcp.2014.01.032_bib0540","doi-asserted-by":"crossref","first-page":"6700","DOI":"10.1073\/pnas.1231994100","article-title":"Copper chelation represses the vascular response to injury","volume":"100","author":"Mandinov","year":"2003","journal-title":"PNAS"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295214000719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295214000719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:58:53Z","timestamp":1757768333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295214000719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":108,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0006295214000719"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2014.01.032","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: Maintenance of brain iron homeostasis","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2014.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}